The Ministry will assess the readiness of participants of the pharmaceutical market to the introduction of marking

From 1 to 11 June, the health Ministry will test the readiness of participants of supply chain to work with marked medicines.

During the event, scheduled work processes of information transfer in the Federal state information system of monitoring the movement of pharmaceuticals related to the shipment of drugs by wholesalers, acceptance of drugs pharmacy and medical organizations, to move drugs between the points, the withdrawal of drugs in a result, retail trade, and other reasons (application, suspension, handling, decommissioning etc.).

To synchronize the activities of test participants Roszdravnadzor, along with the “Operator-CRPT” 21 may 2020 will hold a working meeting in a videoconference mode.

Leave a Reply

Your email address will not be published. Required fields are marked *


“Nanolek” released the first batch of hydroxychloroquine

The company “Nanolek” factory in the Kirov region has established the production of one of the drugs for the treatment of coronavirus infection of hydroxychloroquine. Currently, hydroxychloroquine is included in the treatment protocols in the interim Ministry of health recommendations for the prevention, diagnosis and treatment of new coronavirus infection. The first batch of this […]

Igor Ghahramanyan was returned to the Ministry of health

Senator Igor Ghahramanyan was appointed first Deputy Minister of health of the Russian Federation. In the Federation Council Ghahramanyan presented the Executive authority of the Yaroslavl region and held the position of first Deputy Chairman of Committee on social policy, writes “Kommersant”. From 2012 to 2017 Igor Ghahramanyan was already a Deputy and first Deputy […]

AstraZeneca localized in Russia production of ticagrelor

Company AstraZeneca localized at its own plant in Kaluga region manufacture of the finished dosage form of ticagrelor 90 mg for the treatment of patients with acute coronary syndrome (ACS). Ticagrelor (trade name of Brilinta) is included in the list of essential drugs and included in the standards of specialized medical care for patients with […]